Development of molecularly targeted ther
โ
Andrew X. Zhu; Aram F. Hezel
๐
Article
๐
2011
๐
John Wiley and Sons
๐
English
โ 184 KB
Biliary tract cancers (BTCs), which encompass intra- and extrahepatic cholangiocarcinomas as well as gallbladder carcinomas, are a genetically diverse collection of cancers. Most patients with BTC will present with unresectable or metastatic disease. Although the standard systemic chemotherapy appro